News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
338,716 Results
Type
Article (27331)
Company Profile (148)
Press Release (311237)
Section
Business (96375)
Career Advice (1311)
Deals (15672)
Drug Delivery (78)
Drug Development (39958)
Employer Resources (152)
FDA (8344)
Job Trends (8825)
News (162529)
Policy (14466)
Tag
Academia (1966)
Alliances (26451)
Alzheimer's disease (821)
Approvals (8349)
Artificial intelligence (147)
Bankruptcy (107)
Best Places to Work (7411)
Biotechnology (91)
Breast cancer (136)
Cancer (953)
Cardiovascular disease (85)
Career advice (1150)
Cell therapy (229)
Clinical research (32335)
Collaboration (451)
Compensation (148)
COVID-19 (1326)
C-suite (118)
Data (1074)
Diabetes (135)
Diagnostics (3388)
Earnings (28353)
Employer resources (133)
Events (50319)
Executive appointments (423)
FDA (8964)
Funding (404)
Gene therapy (178)
GLP-1 (379)
Government (2294)
Healthcare (10085)
Infectious disease (1398)
Inflammatory bowel disease (97)
Interviews (195)
IPO (6763)
Job creations (1771)
Job search strategy (1008)
Layoffs (181)
Legal (2603)
Lung cancer (135)
Manufacturing (144)
Medical device (6343)
Medtech (6347)
Mergers & acquisitions (9189)
Metabolic disorders (325)
Neuroscience (1103)
NextGen: Class of 2025 (3693)
Non-profit (3456)
Northern California (1238)
Obesity (169)
Opinion (127)
Patents (78)
People (34665)
Phase I (9254)
Phase II (13875)
Phase III (11972)
Pipeline (416)
Postmarket research (1409)
Preclinical (3984)
Radiopharmaceuticals (125)
Rare diseases (236)
Real estate (3284)
Regulatory (10563)
Research institute (1735)
Resumes & cover letters (165)
Southern California (1004)
Startups (2406)
United States (10798)
Vaccines (290)
Weight loss (112)
Date
Last 7 days (447)
Last 30 days (1558)
Last 365 days (20012)
2025 (3172)
2024 (20468)
2023 (23022)
2022 (29265)
2021 (32079)
2020 (29557)
2019 (25914)
2018 (19347)
2017 (17190)
2016 (16712)
2015 (18790)
2014 (13768)
2013 (11003)
2012 (11447)
2011 (11774)
2010 (10702)
Location
Africa (487)
Arizona (89)
Asia (18978)
Australia (3403)
California (2759)
Canada (872)
China (196)
Colorado (115)
Connecticut (148)
Delaware (84)
Europe (55680)
Florida (439)
Georgia (112)
Illinois (245)
Indiana (221)
Japan (104)
Maryland (386)
Massachusetts (2179)
Michigan (114)
Minnesota (181)
New Jersey (896)
New York (849)
North Carolina (574)
Northern California (1238)
Ohio (111)
Pennsylvania (585)
South America (644)
Southern California (1004)
Texas (347)
Washington State (194)
338,716 Results for "tiziana life sciences plc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Tiziana Life Sciences Announces Long Covid Study to Complete in Second Quarter
February 26, 2025
·
5 min read
Press Releases
Tiziana Life Sciences Announces Agreement for Product Development Services with Renaissance Lakewood, LLC
February 24, 2025
·
6 min read
Press Releases
Tiziana Life Sciences Announces Dosing of Additional Patients in Multiple Sclerosis Expanded Access Program
February 19, 2025
·
5 min read
Press Releases
Tiziana Life Sciences Announces TV Interview with First Patient Dosed with Moderate Alzheimer’s Disease
February 12, 2025
·
6 min read
Press Releases
Tiziana Life Sciences Announces Groundbreaking Study Published in Nature Neuroscience Demonstrating Positive Results for Nasal Anti-CD3 Therapy in Traumatic Brain Injury
February 28, 2025
·
7 min read
Press Releases
Tiziana Life Sciences Announces Positive Results in Treating Spinal Cord Injury With Nasal Anti-CD3
January 23, 2025
·
5 min read
Press Releases
Tiziana Life Sciences Announces Discovery of New Immune Biomarkers in Multiple Sclerosis Patients Treated with Nasal Foralumab
January 23, 2025
·
6 min read
Press Releases
Tiziana Life Sciences Announces Review Article Published in Nature Highlighting Foralumab’s Potential in the Treatment of Neurological Disease
January 9, 2025
·
6 min read
Pharm Country
Tiziana Life Sciences to Dose First Patient with Moderate Alzheimer’s Disease with Foralumab
Tiziana Life Sciences, Ltd. today announced that the U.S. Food and Drug Administration (FDA) has allowed intranasal foralumab to be used under an Expanded Access (EA) IND in its first patient with moderate Alzheimer’s disease.
June 26, 2024
·
3 min read
Pharm Country
Tiziana Life Sciences Files for Orphan Drug Designation for Intranasal Foralumab
Tiziana Life Sciences, Ltd. announced it has submitted an FDA request to obtain Orphan Drug Designation for intranasal foralumab for the treatment of non-active secondary progressive Multiple Sclerosis.
May 13, 2024
·
3 min read
1 of 33,872
Next
